TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000263923 KDR NA NA breast cancer up-regulated predicted more...
ENST00000263923 KDR NA NA breast cancer up-regulated predicted more...
ENST00000263923 KDR NA NA pancreatic cancer up-regulated predicted more...
ENST00000263923 KDR NA NA melanoma up-regulated predicted more...
ENST00000263923 KDR NA NA hepatocellular carcinoma up-regulated predicted more...
ENST00000263923 KDR NA NA endometrial cancer up-regulated predicted more...
ENST00000263923 KDR NA NA non-small cell lung cancer up-regulated predicted more...
ENST00000263923 KDR NA NA ovarian cancer up-regulated predicted more...
ENST00000263923 KDR DB06973 Bisphenol A endothelium dysfunction up-regulated validated more...
ENST00000263923 KDR DB06973 Bisphenol A inflammation up-regulated validated more...
ENST00000263923 KDR DB00482 Celecoxib portal hypertension down-regulated validated more...
ENST00000263923 KDR DB01268 Sunitinib inflammatory corneal down-regulated validated more...
ENST00000263923 KDR DB00518 Albendazole hepatocellular carcinoma down-regulated validated more...
ENST00000263923 KDR DB14844 Dordaviprone medullary thyroid carcinoma down-regulated validated more...
ENST00000263923 KDR DB14765 Rivoceranib extensive-stage small cell lung cancer down-regulated validated more...
ENST00000263923 KDR DB00822 Disulfiram diabetic heart diseases up-regulated validated more...
ENST00000263923 KDR (VEGFR2) NA Spica Prunellae colon cancer down-regulated validated more...